Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.54 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | SRC | P12931 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL808799 | 0.82 | DGAT1 (0.74) | DGAT1ELANEKCNN4ALDH1A1TP53 | |
| Iodide SCHEMBL10533676 | 0.79 | DGAT1 (0.70) | DGAT1ELANEKCNN4ALDH1A1TP53 | |
| Ammonia Solution, Strong SCHEMBL7639328 | 0.79 | DGAT1 (0.70) | DGAT1ELANEKCNN4ALDH1A1TP53 | |
| SCHEMBL23091415 | 0.79 | DGAT1 (0.70) | DGAT1ELANEKCNN4ALDH1A1TP53 | |
| SCHEMBL27905901 | 0.79 | DGAT1 (0.70) | DGAT1ELANEKCNN4ALDH1A1TP53 | |
| SCHEMBL410733 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL29962697 | 0.77 | DGAT1 (0.48) | DGAT1ELANEKCNN4ALDH1A1LMNA | |
| SCHEMBL5859056 | 0.77 | DGAT1 (0.59) | DGAT1ELANEKCNN4ALDH1A1SRC | |
| SCHEMBL22433018 | 0.76 | DGAT1 (0.41) | DGAT1KCNN4ALDH1A1TP53RAB9A | |
| SCHEMBL29115444 | 0.76 | DGAT1 (0.41) | DGAT1KCNN4ALDH1A1TP53RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115297861-B | Compounds and uses thereof | 福宏治疗公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-115297861-A | Compound and use thereof | 福宏治疗公司 | 2022-11-04 | — | — | CN | disclosed |
| US-20090286807-A1 | CYCLIC AMINE COMPOUND | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-11-19 | — | — | US | disclosed |
| EP-2036896-A1 | CYCLIC AMINE COMPOUND | Daiichi Sankyo Company, Limited (JP) | 2009-03-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286807-A1 | CYCLIC AMINE COMPOUND | HRH3, HRH4, H1-0 | DGAT1 3978/4885ELANE 3842/4885KCNN4 573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.